Hematopoietic growth factors: Novel therapeutic strategy for Alzheimer's disease

Drugs of the Future

Volumn 34, Issue 12, 2009, Pages 977-989

  Rowe, A ^a   Eberhard, J ^a   Sanchez Ramos, J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IBUPROFEN; PARACETAMOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1;

ALZHEIMER DISEASE; APOPTOSIS; BONE PAIN; CELL DEATH; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MOTILITY; CELL PROLIFERATION; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEVER; GOUT; HEADACHE; HEMATOPOIESIS; HUMAN; HYPERURICEMIA; INFLAMMATION; INSOMNIA; MICROGLIA; MONOCYTE; NAUSEA; NEURAL STEM CELL; NEUROPROTECTION; NEUTROPENIA; NONHUMAN; PERIPHERAL CIRCULATION; REVIEW; SIDE EFFECT; STROKE; SWEATING; SYNAPSE;

EID: 84930540739     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2009.034.12.1416991     Document Type: Review

References (168)

1. DeKosky, S.T., Scheff, S.W., Styren, S.D. Structural correlates of cognition in dementia: Quantification and assessment of synapse change. Neurodegeneration 1996, 5(4): 417-421
2. Selkoe, D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298(5594): 789-791
3. Swaab, D.F., Dubelaar, E.J., Hofman, M.A., Scherder, E.J., van Someren, E.J., Verwer, R.W. Brain aging and Alzheimer's disease; use it or lose it. Prog Brain Res 2002, 138: 343-373 (Pubitemid 35460922)
4. Schulte-Herbruggen, O., Jockers-Scherubl, M.C., Hellweg, R. Neurotrophins: From pathophysiology to treatment in Alzheimer's disease. Curr Alzheimer Res 2008, 5(1): 38-44.
5. Tuszynski, M.H., Sang, H., Yoshida, K., Gage, F.H. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 1991, 30(5): 625-636
6. Eriksdotter Jonhagen, M., Nordberg, A., Amberia, K. et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease. Dement Geriatr Cogn Disord 1998, 9(5): 246-257 (Pubitemid 28377225)
7. Tuszynski, M.H., Thal, L., Pay, M. et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005, 11(5): 551-555 (Pubitemid 40691288)
8. Yu, J.T., Tan, L., Song, J.H., Sun, Y.P., Chen, W., Miao, D., Tian, Y. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease. Brain Res 2009, 1253: 169-175
9. Combarros, O., Van Duijin, C.M., Hammond, N. et al. Replication by the epistasis project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflammation 2009, 6: 22.
10. Di Bona, D., Candore, G., Franceschi, C. et al. Systematic review by metaanalyses on the possible role of TNF-alpha polymorphisms in association with Alzheimer's disease. Brain Res Rev 2009, 61(2): 60-68
11. Laske, C., Stellos, K., Stransky, E., Leyhe, T., Gawaz, M. Decreased plasma levels of granulocyte-colony stimulating factor (G-CSF) in patients with early Alzheimer's disease. J Alzheimers Dis 2009, 17(1): 115-123
12. Scheffler, B., Horn, M., Blumcke, I., Laywell, E.D., Coomes, D., Kukekov, V.G., Steindler, D.A. Marrow-mindedness: A perspective on neuropoiesis. Trends Neurosci 1999, 22: 348-357
13. Song, S., Sanchez-Ramos, J. Brain as the sea of marrow. Exp Neurol 2003, 184(1): 54-60.
14. Sanchez-Ramos, J. et al. The potential of bone marrow as a source of neural precursors. Neurosci News 2000, 3: 32-43.
15. Gamer, L.W., Wolfman, N.M., Celeste, A.J., Hattersley, G., Hewick, R., Rosen, V. A novel BMP expressed in developing mouse limb, spinal cord, and tail bud is a potent mesoderm inducer in Xenopus embryos. Dev Biol 1999, 208(1): 222-232 (Pubitemid 29149460)
16. Mehler, M.F., Kessler, J.A. Growth factor regulation of neuronal development. Dev Neurosci 1994, 16(3-4): 180-195
17. Mehler, M.F., Mabie, P.C., Zhang, D., Kessler, J.A. Bone morphogenetic proteins in the nervous system. Trends Neurosci 1997, 20(7): 309-317 (Pubitemid 27348741)
18. Daadi, M., Arcellana-Panlilio, M.Y., Weiss, S. Activin co-operates with fibroblast growth factor 2 to regulate tyrosine hydroxylase expression in the basal forebrain ventricular zone progenitors. Neuroscience 1998, 86(3): 867-880 (Pubitemid 28298742)
19. Ling, Z.D., Potter, E.D., Lipton, J.W., Carvey, P.M. Differentiation of mesencephalic progenitor cells into dopaminergic neurons by cytokines. Exp Neurol 1998, 149(2): 411-423
20. Hartung, T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol 1998, 5(3): 221-225 (Pubitemid 28360550)
21. Lu, C.Z., Xiao, B.G. Neuroprotection of G-CSF in cerebral ischemia. Front Biosci 2007, 12: 2869-2875
22. Jung, K.H., Chu, K., Lee, S.T., Kang, L., Kim, S.U., Kim, M., Roh, J.K. G-CSF protects human cerebral hybrid neurons against in vitro ischemia. Neurosci Lett 2006, 394(3): 168-173 (Pubitemid 43144844)
23. Yata, K., Matchett, G.A., Tsubokawa, T., Tang, J., Kanamaru, K., Zhang, J.H. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res 2007, 1145: 227-238 (Pubitemid 46497988)
24. Sanchez-Ramos, J., Song, S., Sava, V. et al. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 2009, 163(1): 55-72.
25. Jung, K.H., Chu, K., Lee, S.T. et al. Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation. Brain Res 2006, 1073-1074: 190-201.
26. Toth, Z.E., Leker, R.R., Shahar, T. et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008, 111(12): 5544-5552
27. Shyu, W.C., Lin, S.Z., Yang, H.I., Tzeng, Y.S., Pang, C.Y., Yen, P.S., Li, H. Functional recovery of stroke rats induced by granulocyte colony-stimulating factor-stimulated stem cells. Circulation 2004, 110(13): 1847-1854 (Pubitemid 39299228)
28. Bell, R.D., Zlokovic, B.V. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease. Acta Neuropathol 2009, 118(1): 103-113
29. Wells, J.A., de Vos, A.M. Hematopoietic receptor complexes. Annu Rev Biochem 1996, 65: 609-634
30. Sanchez-Ramos, J., Song, S., Cao, C., Arendash, G. The potential of hematopoietic growth factors for treatment of Alzheimer's disease: A mini-review. BMC Neurosci 2008, 9(Suppl. 2): S3.
31. Demetri, G.D., Griffin, J.D. Granulocyte colony-stimulating factor and its receptor. Blood 1991, 78(11): 2791-2808
32. Malipiero, U.V., Frei, K., Fontana, A. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990, 144(10): 3816-3821
33. Bussolino, F., Wang, J.M., Defilippi, P. et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337(6206): 471-473
34. Morikawa, K., Morikawa, S., Nakamura, M., Miyawaki, T. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Haematol 2002, 118(1): 296-304.
35. Shimoda, K., Okamura, S., Harada, N., Kondo, S., Okamura, T., Niho, Y. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 1993, 91(4): 1310-1313 (Pubitemid 23127326)
36. Hanazono, Y., Hosoi, T., Kuwaki, T., Matsuki, S., Miyazono, K., Miyagawa, K., Takaku, F. Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. Exp Hematol 1990, 18(10): 1097-1103
37. Schneider, A., Krüger, C., Steigleder, T. et al. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. J Clin Invest 2005, 115(8): 2083-2098 (Pubitemid 41134150)
38. Hunter, M.C., Avalos, B.R. Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphatase (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor receptor. J Immunol 1998, 160(10): 4979-4987
39. Shimoda, K., Feng, J., Murakami, H. et al. Jakl plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 1997, 90(2): 597-604. (Pubitemid 27299099)
40. Tian, S.S., Lamb, P., Seidel, H.M., Stein, R.B., Rosen, J. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 1994, 84(6): 1760-1764 (Pubitemid 24286124)
41. Ward, A.C., Loeb, D.M., Soede-Bobok, A.A., Touw, I.P., Friedman, A.D. Regulation of granulopoiesis by transcription factors and cytokine signals. Leukemia 2000, 14(6): 973-990 (Pubitemid 30389501)
42. Dong, F., Larner, A.C. Activation of Akt kinase by granulocyte colony-stimulating factor (G-CSF): Evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood 2000, 95(5): 1656-1662 (Pubitemid 30120826)
43. Crea, F., Giovannetti, E., Zinzani, P.L., Danesi, R. Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization. Crit Rev Oncol Hematol 2009, 72(1): 21-44.
44. Kleinschnitz, C., Schroeter, M., Jander, S., Stoll, G. Induction of granulocyte colony-stimulating factor mRNA by focal cerebral ischemia and cortical spreading depression. Mol Brain Res 2004, 131(1-2): 73-78 (Pubitemid 39458279)
45. Kawada, H., Takizawa, S., Takanashi, T. et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006, 113(5): 701-710 (Pubitemid 43754334)
46. Solaroglu, I., Jadhav, V., Zhang, J.H. Neuroprotective effect of granulocyte-colony stimulating factor. Front Biosci 2007, 12: 712-724 (Pubitemid 46852816)
47. Bodine, D.M., Seidel, N.E., Gale, M.S., Nienhuis, A.W., Orlic, D. Efficient retrovirus transduction of mouse pluripotent hematopoietic stem cells mobilized into the peripheral blood by treatment with granulocyte colony-stimulating factor and stem cell factor. Blood 1994, 84(5): 1482-1491 (Pubitemid 24273016)
48. Orlic, D., Kajstura, J., Chimenti, S. et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 2001, 98(18): 10344-10349 (Pubitemid 32803022)
49. Orlic, D., Kajstura, J., Chimenti, S. et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410(6829): 701-705 (Pubitemid 32290358)
50. Grigg, A.P., Roberts, A.W., Raunow, H. et al. Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995, 86(12): 4437-4445
51. Tsai, K.J., Tsai, Y.C., Shen, C.K. G-CSF rescues the memory impairment of animal models of Alzheimer's disease. J Exp Med 2007, 204(6): 1273-1280 (Pubitemid 46919864)
52. Arendash, G.W., King, D.L., Gordon, M.N., Morgan, D., Hatcher, J.M., Hope, C.E., Diamond, D.M. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 2001, 891(1-2): 42-53. (Pubitemid 32115494)
53. Ethell, D.W., Shippy, D., Cao, C., Cracchiolo, J.R., Runfeldt, M., Blake, B., Arendash, G.W. Abeta-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol Dis 2006, 23(2): 351-361 (Pubitemid 44097033)
54. Arendash, G.W., Schleif, W., Rezai-Zadeh, K. et al. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 2006, 142(4): 941-952
55. Casadesus, G., Webber, K.M., Atwood, C.S., Pappolla, M.A., Perry, G., Bowen, R.L., Smith, M.A. Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice. Biochim Biophys Acta 2006, 1762(4): 447-452 (Pubitemid 43344306)
56. Hickman, S.E., Allison, E.K., El Khoury, J. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008, 28(33): 8354-8360
57. Boneberg, E.M., Hareng, L., Gantner, F., Wendel, A., Hartung, T. Human monocytes express functional receptors for granulocyte colony-stimulating factor that mediate suppression of monokines and interferon-gamma. Blood 2000, 95(1): 270-276 (Pubitemid 30017252)
58. Hsia, A.Y., Masliah, E., McConlogue, L. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc Natl Acad Sci U S A 1999, 96(6): 3228-3233 (Pubitemid 29148873)
59. Mucke, L., Masliah, E., Yu, G.Q. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 2000, 20(11): 4050-4058 (Pubitemid 30365675)
60. Oddo, S., Caccamo, A., Shepherd, D.H. et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular A[beta] and synaptic dysfunction. Neuron 2003, 39(3): 409-421 (Pubitemid 36937044)
61. Lombardo, J.A., Stern, E.A., McLellan, M.E., Kajdasz, S.T., Hickey, G.A., Bacskai, B.J., Hyman, B.T. Amyloid-beta antibody treatment leads to rapid normalization of plaque- induced neuritic alterations. J Neurosci 2003, 23(34): 10879-10883
62. Carlsson, G., Ahlin, A., Dahllöf, G., Elinder, G., Henter, J.I., Palmblad, J. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia. Br J Haematol 2004, 126(1): 127-132 (Pubitemid 38859493)
63. Kocherlakota, P., La Gamma, E.F. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia. Pediatrics 1997, 100(1): E6.
64. Welte, K., Gabrilove, J., Bronchud, M.H., Platzer, E., Morstyn, G. Filgrastim (r-metHuG-CSF): The first 10 years. Blood 1996, 88(6): 1907-1929.
65. Schabitz, W.R., Schneider, A. Developing granulocyte-colony stimulating factor for the treatment of stroke: Current status of clinical trials. Stroke 2006, 37(7): 1654; author reply 1655. (Pubitemid 44297704)
66. Takano, H., Ohtsuka, M., Akazawa, H. et al. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 2003, 9(14): 1121-1127 (Pubitemid 36443213)
67. Kuethe, F., Figulla, H.R., Voth, M. et al. [Mobilization of stem cells by granulocyte colony-stimulating factor for the regeneration of myocardial tissue after myocardial infarction]. Dtsch Med Wochenschr 2004, 129(9): 424-428
68. Nienaber, C.A., Petzsch, M., Kleine, H.D., Eckard, H., Freund, M., Ince, H. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med 2006, 3(Suppl. 1): S73-7.
69. Ripa, R.S., Jørgensen, E., Wang, Y. et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: Result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006, 113(16): 1983-1992.
70. Suzuki, K., Nagashima, K., Arai, M. et al. Effect of granulocyte colony-stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. Circ J 2006, 70(4): 430-437
71. Sanchez-Ramos, J. Clinical trial supported by AD Drug Discovery Foundation "Efficacy and Safety of Filgastrim as a Procognitive Agent in Alzheimer's Disease". 2009.
72. de la Rubia, J., de Arriba, F., Arbona, C. et al. Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry. Haematologica 2008, 93(5): 735-740
73. Stroncek, D.F., Dittmar, K., Shawker, T., Heatherman, A., Leitman, S.F. Transient spleen enlargement in peripheral blood progenitor cell donors given G-CSF. J Transl Med 2004, 2(1): 25.
74. Tigue, C.C., McKoy, K.M., Evens, A.M., Trifilio, S.M., Tallman, M.S., Bennett, C.L. Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: An overview of safety considerations from the Research on Adverse Drug Events and Reports project. Bone Marrow Transplant 2007 40(3): 185-192
75. Broudy, V.C. Stem cell factor and hematopoiesis. Blood 1997, 90(4): 1345-64.
76. Hirota, S., Ito, A., Morii, E., Wanaka, A., Tohyama, M., Kitamura, Y., Nomura, S. Localization of mRNA for c-kit receptor and its ligand in the brain of adult rats: An analysis using in situ hybridization histochemistry. Mol Brain Res 1992, 15(1-2): 47-54.
77. Matsui, Y., Zsebo, K.M., Hogan, B.L.M. Embryonic expression of a haematopoietic growth factor encoded by the SI locus and the ligand for c-kit. Nature 1990, 347(6294): 667-669
78. Morii, E., Hirota, S., Kim, H.M., Mikoshiba, K., Nishimune, Y., Kitamura, Y., Nomura, S. Spatial expression of genes encoding c-kit receptors and their ligands in mouse cerebellum as revealed by in situ hybridization. Brain Res Dev Brain Res 1992, 65(1): 123-126
79. Akin, C., Metcalfe, D.D. The biology of Kit in disease and the application of pharmacogenetics. J Allergy Clin Immunol 2004, 114(1): 13-9; quiz 20.
80. Erlandsson, A., Larsson, J., Forsberg-Nilsson, K. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 2004, 301(2): 201-210 (Pubitemid 39504973)
81. Jin, K., Mao, X.O., Sun, Y., Xie, L., Greenberg, D.A. Stem cell factor stimulates neurogenesis in vitro and in vivo. J Clin Invest 2002, 110(3): 311-319
82. Dhandapani, K.M., Wade, F.M., Wakade, C., Mahesh, V.B., Brann, D.W. Neuroprotection by stem cell factor in rat cortical neurons involves AKT and NFkappaB. J Neurochem 2005, 95(1): 9-19. (Pubitemid 41384421)
83. Zhang, S.-C., Fedoroff, S. Expression of stem cell factor and c-kit receptor in neural cells after brain injury. Acta Neuropathol 1999, 97(4): 393-398 (Pubitemid 29134520)
84. Sun, L., Lee, J., Fine, H.A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004, 113(9): 1364-1374 (Pubitemid 39069935)
85. Corti, S., Locatelli, F., Strazzer, S. et al. Modulated generation of neuronal cells from bone marrow by expansion and mobilization of circulating stem cells with in vivo cytokine treatment. Exp Neurol 2002, 177(2): 443-452 (Pubitemid 35366133)
86. Zhao, L.-R., Navalitloha, Y., Singhal, S. et al. Hematopoietic growth factors pass through the blood-brain barrier in intact rats. Exp Neurol 2007, 204(2): 569-573 (Pubitemid 46497044)
87. Leyhe, T., Hoffmann, N., Stransky, E., Laske, C. Increase of SCF plasma concentration during donepezil treatment of patients with early Alzheimer's disease. Int J Neuropsychopharmacol 2009, 12(10): 1319-1326
88. Zhang, S.-C., Fedoroff, S. Modulation of microglia by stem cell factor. J Neurosci Res 1998, 53(1): 29-37. (Pubitemid 28308979)
89. Katafuchi, T., Li, A.J., Hirota, S., Kitamura, Y., Hori, T. Impairment of spatial learning and hippocampal synaptic potentiation in c-kit mutant rats. Learning Memory 2000, 7(6): 383-392 (Pubitemid 32003245)
90. Laske, C., Stellos, K., Stransky, E. et al. Decreased plasma and cerebrospinal fluid levels of stem cell factor in patients with early Alzheimer's disease. J Alzheimer's Dis 2008, 15(3): 451-460
91. Miyazawa, K., Williams, D.A., Gotoh, A., Nishimaki, J., Broxmeyer, H.E., Toyama, K. Membrane-bound Steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood 1995, 85(3): 641-649
92. Piao, C.-S., Gonzalez-Toledo, M.E., Xue, Y.Q. et al. The role of stem cell factor and granulocyte-colony stimulating factor in brain repair during chronic stroke. J Cereb Blood Flow Metab 2009, 29(4): 759-770
93. Nicola, N.A. GM-CSF. In: Cytokine Reference. Oppenheim, J.J., Feldmann, M. (Eds.). San Diego: Academic Press, 2001.
94. Koguchi, K., Nakatsuji, Y., Okuno, T., Sawada, M., Sakoda, S. Microglial cell cycle-associated proteins control microglial proliferation in vivo and in vitro and are regulated by GM-CSF and density-dependent inhibition. J Neurosci Res 2003, 74(6): 898-905. (Pubitemid 37490423)
95. Schabitz, W.R., Krüger, C., Pitzer, C. et al. A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 2008, 28(1): 29-43.
96. Maurer, M.H., Schäbitz, W.R., Schneider, A. Old friends in new constellations - The hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. Curr Med Chem 2008, 15(14): 1407-1411
97. Sawada, M., Itoh, Y., Suzumura, A., Marunouchi, T. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett 1993, 160(2): 131-134
98. Guillemin, G., Boussin, F.D., Le Grand, R., Croitoru, J., Coffigny, H., Dormont, D. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 1996, 16(1): 71-80.
99. Kruger, C., Laage, R., Pitzer, C., Schäbitz, W.R. Schneider, A. The hematopoietic factor GM-CSF (granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro. BMC Neurosci 2007, 8: 88.
100. Mirski, R., Reichert, F., Klar, A., Rotshenker, S. Granulocyte macrophage colony stimulating factor (GM-CSF) activity is regulated by a GM-CSF binding molecule in Wallerian degeneration following injury to peripheral nerve axons. J Neuroimmunol 2003, 140(1-2): 88-96. (Pubitemid 36836093)
101. Reichert, F., Saada, A., Rotshenker, S. Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: Phagocytosis and the galactose-specific lectin MAC-2. J Neurosci 1994, 14(5): 3231-3245 (Pubitemid 24139006)
102. Schermer, C., Humpel, C. Granulocyte macrophage-colony stimulating factor activates microglia in rat cortex organotypic brain slices. Neurosci Lett 2002, 328(2): 180-184
103. Suzumura, A., Sawada, M., Marunouchi, T. Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor. Brain Res 1996, 713(1-2): 192-198 (Pubitemid 26114840)
104. Coxon, A., Tang, T., Mayadas, T.N. Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo: A role for granulocyte/ macrophage colony-stimulating factor. J Exp Med 1999, 190(7): 923-934
105. Ha, Y. Synthes Award for Resident Research on Spinal Cord and Spinal Column Injury: Granulocyte macrophage colony stimulating factor (GM-CSF) prevents apoptosis and improves functional outcome in experimental spinal cord contusion injury. Clin Neurosurg 2005, 52: 341-347
106. Manczak, M., Mao, P., Nakamura, K., Bebbington, C., Park, B., Reddy, P.H. Neutralization of granulocyte macrophage colony stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Hum Mol Genet 2009, 18(20): 3876-3893
107. Tarkowski, E., Wallin, A., Regland, B., Blennow, K., Tarkowski, A. Local and systemic GM-CSF increase in Alzheimer's disease and vascular dementia. Acta Neurol Scand 2001, 103(3): 166-174 (Pubitemid 32162162)
108. Kim, H.-D., Kong, F.K., Cao, Y., Lewis, T.L., Kim, H., Tang, D.C., Fukuchi, K. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid [beta]-protein and GM-CSF reduces amyloid load in the brain. Neurosci Lett 2004, 370(2-3): 218-223
109. DaSilva, K.A., Brown, M.E., Westaway, D., McLaurin, J. Immunization with amyloid-[beta] using GM-CSF and IL-4 reduces amyloid burden and alters plaque morphology. Neurobiol Dis 2006, 23(2): 433-444 (Pubitemid 44080847)
110. Tarkowski, E., Rosengren, L., Blomstrand, C., Wikkelsö, C., Jensen, C., Ekholm, S., Tarkowski, A. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol 1997, 110(3): 492-499 (Pubitemid 27525284)
111. Tarkowski, E., Andreasen, N., Tarkowski, A., Blennow, K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003, 74(9): 1200-1205 (Pubitemid 37152241)
112. Stanley, E.R. Colony stimulating factor-1 (macrophage colony stimulating factor). In: The Cytokine Handbook. Thomson, A.W. (Ed.). San Diego: Academic Press, 1994, 387-418.
113. Giulian, D., Ingeman, J.E. Colony-stimulating factors as promoters of ameboid microglia. J Neurosci 1988, 8(12): 4707-4717
114. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G., Rivest, S. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 2009, 132(Pt. 4): 1078-1092
115. Davoust, N., Vuaillat, C., Cavillon, G. et al. Bone marrow CD34+/B220+ progenitors target the inflamed brain and display in vitro differentiation potential toward microglia. FASEB J 2006, 20(12): 2081-2092
116. Raivich, G., Moreno-Flores, M.T., Möller, J.C., Kreutzberg, G.W. Inhibition of posttraumatic microglial proliferation in a genetic model of macrophage colony-stimulating factor deficiency in the mouse. Eur J Neurosci 1994, 6(10): 1615-1618 (Pubitemid 24310369)
117. Vidyadaran, S., Ooi, Y.Y., Subramaiam, H., Badiei, A., Abdullah, M., Ramasamy, R., Seow, H.F. Effects of macrophage colony-stimulating factor on microglial responses to lipopolysaccharide and beta amyloid. Cell Immunol 2009, 259(1): 105-110
118. Ray, S., Britschgi, M., Herbert, C. et al. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat Med 2007, 13(11): 1359-1362 (Pubitemid 350073592)
119. Lapidot, T., Dar, A., Kollet, O. How do stem cells find their way home? Blood 2005, 106(6): 1901-1910
120. Zhou, B., Han, Z.C., Poon, M.C., Pu, W. Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: Enhancement of cell recruitment and entrapment. Med Hypotheses 2007, 68(6): 1268-1271 (Pubitemid 46509696)
121. Aiuti, A., Webb, I.J., Bleul, C., Springer, T., Gutierrez-Ramos, J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185(1): 111-120 (Pubitemid 27039446)
122. Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A., Springer, T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184(3): 1101-1109
123. Carr, A.N., Howard, B.W., Yang, H.T. et al. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: Support for an endothelium-dependent mechanism. Cardiovasc Res 2006, 69(4): 925-935
124. Langer, H., May, A.E., Daub, K. et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006, 98(2): e2-10. (Pubitemid 43755340)
125. Stellos, K., Langer, H., Daub, K. et al. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 2008, 117(2): 206-215
126. Robin, A.M., Zhang, Z.G., Wang, L. et al. Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 2006, 26(1): 125-134 (Pubitemid 41818076)
127. Stumm, R., Hollt, V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: Implications for neuronal regeneration in the adult brain. J Mol Endocrinol 2007, 38(3): 377-382 (Pubitemid 46723253)
128. Laske, C., Stellos, K., Eschweiler, G.W., Leyhe, T., Gawaz, M. Decreased CXCL12 (SDF-1) plasma levels in early Alzheimer's disease: A contribution to a deficient hematopoietic brain support? J Alzheimers Dis 2008, 15(1): 83-95.
129. Maiese, K., Li, F., Chong, Z.Z. Erythropoietin in the brain: Can the promise to protect be fulfilled? Trends Pharmacol Sci 2004, 25(11): 577-583
130. Maiese, K., Li, F., Chong, Z.Z. New avenues of exploration for erythropoietin. JAMA 2005, 293(1): 90-95 (Pubitemid 40066704)
131. Chong, Z.Z., Kang, J.Q., Maiese, K. Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 2002, 22(5): 503-514 (Pubitemid 34477771)
132. Fliser, D., Haller, H. Erythropoietin and treatment of non-anemic conditions-cardiovascular protection. Semin Hematol 2007, 44(3): 212-217 (Pubitemid 47031230)
133. Jacobson, L.O., Goldwasser, E., Fried, W., Plzak, L. Role of the kidney in erythropoiesis. Nature 1957, 179(4560): 633-634
134. Lasne, F., de Ceaurriz, J. Recombinant erythropoietin in urine. Nature 2000, 405(6787): 635.
135. Sathyanarayana, P., Menon, M.P., Bogacheva, O. et al. Erythropoietin modulation of podocalyxin and a proposed erythroblast niche. Blood 2007, 110(2): 509-518
136. Schmeding, M., Neumann, U.P., Boas-Knoop, S., Spinelli, A., Neuhaus, P. Erythropoietin reduces ischemia-reperfusion injury in the rat liver. Eur Surg Res 2007, 39(3): 189-197 (Pubitemid 46633182)
137. Fisher, J.W. Erythropoietin: Physiology and pharmacology update. Exp Biol Med (Maywood) 2003, 228(1): 1-14.
138. Brines, M.L., Ghezzi, P., Keenan, S. et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 2000, 97(19): 10526-10531
139. Juul, S.E., Yachnis, A.T., Rojiani, A.M., Christensen, R.D. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 1999, 2(2): 148-158 (Pubitemid 29130201)
140. Marti, H.H., Wenger, R.H., Rivas, L.A. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996, 8(4): 666-676 (Pubitemid 26114611)
141. Morishita, E., Masuda, S., Nagao, M., Yasuda, Y., Sasaki, R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 1997, 76(1): 105-116
142. Sairanen, T., Karjalainen-Lindsberg, M.L., Paetau, A., Ijäs, P., Lindsberg, P.J. Apoptosis dominant in the periinfarct area of human ischaemic stroke - A possible target of antiapoptotic treatments. Brain 2006, 129(Pt. 1): 189-199 (Pubitemid 43063770)
143. Sirén, A.L., Knerlich, F., Poser, W., Gleiter, C.H., Brück, W., Ehrenreich, H. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain. Acta Neuropathol 2001, 101(3): 271-276 (Pubitemid 32219761)
144. Juul, S.E., Statlings, S.A., Christensen, R.D. Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr Res 1999, 46(5): 543-547
145. Springborg, J.B., Sonne, B., Frederiksen, H.J. et al. Erythropoietin in the cerebrospinal fluid of patients with aneurysmal subarachnoid haemorrhage originates from the brain. Brain Res 2003, 984(1-2): 143-148 (Pubitemid 36976803)
146. Assaraf, M.I., Diaz, Z., Liberman, A. et al. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol 2007, 66(5): 389-398 (Pubitemid 46701321)
147. Barkats, M., Millecamps, S., Abrioux, P., Geoffroy, M.C., Mallet, J. Overexpression of glutathione peroxidase increases the resistance of neuronal cells to Abeta-mediated neurotoxicity. J Neurochem 2000, 75(4): 1438-46.
148. Boldogh, I., Kruzel, M.L. Colostrinin: An oxidative stress modulator for prevention and treatment of age-related disorders. J Alzheimers Dis 2008, 13(3): 303-321
149. Moon, J.H., Kim, S.Y., Lee, H.G., Kim, S.U., Lee, Y.B. Activation of nicotinic acetylcholine receptor prevents the production of reactive oxygen species in fibrillar beta amyloid peptide (1-42)-stimulated microglia. Exp Mol Med 2008, 40(1): 11-18
150. Sultana, R., Newman, S., Mohmmad-Abdul, H., Keller, J.N., Butterfield,
151. Li, G., Ma, R., Huang, C. et al. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci Lett 2008, 442(2): 143-147
152. Ma, R., Ma, R., Huang, C. Erythropoietin protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K/Akt signaling pathway. Neuropharmacology 2009, 56(6-7): 1027-1034
153. Bornemann, K.D., Wiederhold, K.H., Paupli, C. et al. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice. Am J Pathol 2001, 158(1): 63-73.
154. Chong, Z.Z., Li, F., Maiese, K. Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 2005, 75(3): 207-246 (Pubitemid 40693131)
155. Chong, Z.Z., Li, F., Maiese, M. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. Histol Histopathol 2005, 20(1): 299-315. (Pubitemid 40029007)
156. Kang, J.Q., Chong, Z.Z., Maiese, K. Aktl protects against inflammatory microglial activation through maintenance of membrane asymmetry and modulation of cysteine protease activity. J Neurosci Res 2003, 74(1): 37-51.
157. Kang, J.Q., Chong, Z.Z., Maiese, K. Critical role for Akt1 in the modulation of apoptotic phosphatidylserine exposure and microglial activation. Mol Pharmacol 2003, 64(3): 557-569 (Pubitemid 37048558)
158. Wang, C.Y., Mayo, M.W., Korneluk, R.G., Goeddel, D.V., Baldwin, A.S. Jr. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998, 281(5383): 1680-3.
159. Reed, J.C. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol Med 2001, 7(7): 314-319 (Pubitemid 32606571)
160. Chong, Z.Z., Li, F., Maiese, K. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity. Curr Neurovasc Res 2005, 2(5): 387-399 (Pubitemid 41789605)
161. Jamsa, A., Hasslund, K., Cowburn, R.F., Bäckström, A., Vasänge, M. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem Biophys Res Commun 2004, 319(3): 993-1000. (Pubitemid 38739418)
162. Ishizawa, T., Sahara, N., Ishiguro, K. et al. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am J Pathol 2003, 163(3): 1057-1067 (Pubitemid 37040141)
163. Sun, Z.K., Yang, H.Q., Pan, J., Zhen, H., Wang, Z.Q., Chen, S.D., Ding, J.Q. Protective effects of erythropoietin on tau phosphorylation induced by beta- amyloid. J Neurosci Res 2008, 86(13): 3018-3027
164. Danielyan, L., Schäfer, R., Schulz, A. et al. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: The critical role of erythropoietin. Cell Death Differ 2009, 16(12): 1599-1614
165. Zwezdaryk, K.J., Coffelt, S.B., Figueroa, Y.G. et al. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Exp Hematol 2007, 35(4): 640-652
166. Tsang, S.W., Pomakian, J., Marshall, G.A. et al. Disrupted muscarinic M1 receptor signaling conelates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease. Neurobiol Aging 2007, 28(9): 1381-1387 (Pubitemid 47081227)
167. Robinson, S.R. Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int 2000, 36(4-5): 471-482
168. de Hemptinne, I., Vermeiren, C., Maloteaux, J.M., Hermans, E. Induction of glial glutamate transporters in adult mesenchymal stem cells. J Neurochem 2004, 91(1): 155-166 (Pubitemid 39314946)